GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 24 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $574,818 | -33.9% | 1,347,755 | -22.5% | 0.02% | -43.2% |
| Q4 2022 | $869,835 | +55.9% | 1,739,670 | -3.3% | 0.04% | +60.9% |
| Q3 2022 | $558,000 | -54.4% | 1,799,694 | 0.0% | 0.02% | -61.0% |
| Q2 2022 | $1,224,000 | -57.2% | 1,799,694 | 0.0% | 0.06% | -48.2% |
| Q1 2022 | $2,862,000 | -12.6% | 1,799,694 | 0.0% | 0.11% | -4.2% |
| Q4 2021 | $3,275,000 | -34.8% | 1,799,694 | 0.0% | 0.12% | -39.3% |
| Q3 2021 | $5,021,000 | -8.2% | 1,799,694 | 0.0% | 0.20% | -4.4% |
| Q2 2021 | $5,471,000 | -11.4% | 1,799,694 | 0.0% | 0.20% | -11.3% |
| Q1 2021 | $6,173,000 | +10.3% | 1,799,694 | 0.0% | 0.23% | +5.0% |
| Q4 2020 | $5,597,000 | -11.9% | 1,799,694 | 0.0% | 0.22% | -36.4% |
| Q3 2020 | $6,353,000 | -26.2% | 1,799,694 | 0.0% | 0.35% | -34.7% |
| Q2 2020 | $8,603,000 | +35.7% | 1,799,694 | -1.8% | 0.53% | -10.3% |
| Q1 2020 | $6,340,000 | -40.1% | 1,832,484 | 0.0% | 0.59% | -26.4% |
| Q4 2019 | $10,592,000 | +20.9% | 1,832,484 | 0.0% | 0.80% | -12.7% |
| Q3 2019 | $8,759,000 | -35.0% | 1,832,484 | 0.0% | 0.92% | -37.5% |
| Q2 2019 | $13,469,000 | -12.2% | 1,832,484 | -2.5% | 1.47% | -14.4% |
| Q1 2019 | $15,347,000 | +19.6% | 1,878,508 | 0.0% | 1.72% | +2.4% |
| Q4 2018 | $12,830,000 | -46.4% | 1,878,508 | +6.6% | 1.68% | -20.2% |
| Q3 2018 | $23,922,000 | +14.1% | 1,761,567 | 0.0% | 2.10% | +2.7% |
| Q2 2018 | $20,963,000 | – | 1,761,567 | – | 2.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|